Peptides
Semax is one of the most scientifically validated nootropic peptides available, yet it remains largely unknown outside of Russia and Eastern Europe. Developed in the 1980s by researchers at the Russian Academy of Sciences, this seven-amino-acid peptide (Met-Glu-His-Phe-Pro-Gly-Pro) has earned an official place on Russia's List of Vital
Peptides
Selank modulates GABA, BDNF, enkephalins, and serotonin simultaneously — delivering anxiolytic effects comparable to benzodiazepines, without dependence, sedation, or cognitive impairment.
If longevity research has a peptide that stands apart from the crowd, it is Epithalon — a tiny four-amino-acid chain with a remarkable body of science behind it. Originating from the pineal gland, Epithalon (also spelled Epitalon) has been studied for more than 25 years in cell cultures, animal models, and
Peptides
PT-141, known generically as bremelanotide, is one of the most scientifically novel peptides in the sexual health space. Unlike Viagra, Cialis, or any other ED treatment you've heard of, PT-141 doesn't work on blood flow — it works on the brain. It activates the neural pathways responsible
Peptides
If you've spent any time researching peptides for growth hormone optimization, you've almost certainly encountered the name CJC-1295. Often stacked with ipamorelin, it's become the foundation of the most widely used GH secretagogue protocol in clinical and research settings. But what exactly is CJC-1295,
Peptides
Peptides
If you've spent any time in the peptide space, you've likely come across TB-500 — a synthetic analog of Thymosin Beta-4 (Tβ4), a small protein found in virtually every cell in the human body. Praised for its ability to accelerate tissue repair, reduce inflammation, and support recovery
GLP-1
A once-daily pill you can take any time — with food, without food, with coffee, without water restrictions — has arrived. Orforglipron (brand name Foundayo), developed by Eli Lilly, is the world's first oral non-peptide GLP-1 receptor agonist. The FDA approved it in April 2026, and it represents a genuine
Peptides
Peptides
Chronic kidney disease quietly destroys lives. An estimated 850 million people worldwide live with CKD, and in the United States alone, more than 37 million adults carry the diagnosis. Most never know it until their kidneys are already badly damaged. For decades, treatment options for slowing CKD progression were limited
GLP-1
The landmark SURMOUNT-5 trial proved tirzepatide produces 47% more weight loss than semaglutide. Here's everything you need to know about dosing, side effects, cardiovascular outcomes, and the 2026 legal status of compounded tirzepatide.